M D Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT05077072
This phase II trial compares different pain management interventions (standard of care [SOC], neurofeedback [NFB] training, and compassionate high alert team [CHAT]) in patients diagnosed with head and neck cancer who are at risk of developing non-medical opioid use (NMOU). The current standard treatment includes regular clinic visits and supportive care and counseling (including topics like patient-doctor communication, cancer care goals, financial issues counseling, and other topics). NFB training is a type of therapy that uses an electroencephalograph (EEG) and a computer software program to measure brain wave activity. The goal of NFB is to help teach patients with pain how to change their own brain waves to lower their feelings of pain and help improve their quality of life. CHAT is a supportive care intervention that includes symptom and pain management, counseling (about pain, symptoms, opioid use and safety, stress, and quality of life), and support for patients and their family members. NFB and CHAT may help to manage pain and lower patient use of opioids.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Phase 2
Houston, Texas, 77030, United States
PRIMARY OBJECTIVE:
I. To test the hypothesis that this study will be feasible, as defined by adequate rates of adherence in the CHAT and NFB groups.
SECONDARY OBJECTIVES:
I. To examine the frequency of NMOU behaviors at the end of 3 months after CHAT, NFB, and SOC.
II. Examine the pain severity (area under the curve [AUC]), daily opioid use AUC of the cumulative morphine equivalent daily dose (MEDD), and mood (Hospital Anxiety and Depression Scale, HADS) for each of the treatment arms (CHAT, NFB, or SOC) in head and neck cancer (HNC) patients receiving radiation therapy at the end of 3 months.
EXPLORATORY OBJECTIVE:
I. To examine the cortical and subcortical regions of the brain associated with pain and our interventions (CHAT, NFB, and SOC) and the extent to which changes in electroencephalogram (EEG) patterns mediate the effects of the intervention.
OUTLINE: Patients are randomized into 1 of 3 arms.
ARM I: Patients participate in CHAT counseling intervention over 45-60 minutes twice a month for up to 12 weeks.
ARM II: Patients undergo NFB intervention over 20-30 minutes twice a week for up to 10 weeks.
ARM III: Patients receive 2-3 standard of care sessions per month over 45-60 minutes for up to 12 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Receive SOC
Other names: standard of care, standard therapy
Participate in CHAT counseling intervention
Other names: Counseling Intervention
Undergo EEG
Other names: EEG, electroencephalogram
Undergo NFB intervention
Other names: EEG biofeedback
Ancillary studies
Time frame: through study completion, an average of a year.
Composite NMOU score is calculated by summing the number of times each behavior suggestive of NMOU is recorded.
M.D. Anderson Cancer Center
Other
Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02465060
Adenocarcinoma, Adnexal Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT03612531
Cancer Survivor, Deglutition Disorders
Houston, Texas, United States
View Trial DetailsNCT05075980
Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Carcinoma
Phoenix, Arizona, United States
View Trial DetailsNCT07118176
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial Details